F. Ruiz

1.0k total citations
16 papers, 553 citations indexed

About

F. Ruiz is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, F. Ruiz has authored 16 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in F. Ruiz's work include Cystic Fibrosis Research Advances (7 papers), Neonatal Respiratory Health Research (6 papers) and Pulmonary Hypertension Research and Treatments (6 papers). F. Ruiz is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Neonatal Respiratory Health Research (6 papers) and Pulmonary Hypertension Research and Treatments (6 papers). F. Ruiz collaborates with scholars based in United States and Chile. F. Ruiz's co-authors include John P. Clancy, Eric J. Sorscher, Raymond K. Lyrene, Jeong S. Hong, David M. Bedwell, Chris King, Maurizio Macaluso, Zsuzsa Bebők, Mark Weatherly and Jerry R. McGhee and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, PEDIATRICS and American Journal of Physiology-Cell Physiology.

In The Last Decade

F. Ruiz

14 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Ruiz United States	8	310	215	71	59	55	16	553
L. J. MacVinish United Kingdom	17	252 0.8×	413 1.9×	133 1.9×	24 0.4×	74 1.3×	27	713
R C Boucher United States	7	466 1.5×	473 2.2×	218 3.1×	45 0.8×	53 1.0×	8	906
Qinshi Jiang United States	8	185 0.6×	255 1.2×	74 1.0×	39 0.7×	19 0.3×	10	445
X.B. Chang Canada	9	680 2.2×	495 2.3×	117 1.6×	15 0.3×	80 1.5×	10	1.1k
Xiaowei Chang Canada	8	422 1.4×	321 1.5×	21 0.3×	16 0.3×	38 0.7×	12	631
Cynthia B. Robinson United States	9	145 0.5×	163 0.8×	88 1.2×	12 0.2×	76 1.4×	11	378
Valeria Tomati Italy	20	783 2.5×	449 2.1×	72 1.0×	12 0.2×	119 2.2×	42	1.1k
Inna Uliyakina Portugal	12	300 1.0×	334 1.6×	41 0.6×	7 0.1×	65 1.2×	13	625
Lap-Chee Tsui Canada	9	1.0k 3.2×	389 1.8×	118 1.7×	16 0.3×	25 0.5×	9	1.3k
Tanja Rezzonico Jost Switzerland	8	55 0.2×	188 0.9×	14 0.2×	59 1.0×	84 1.5×	16	629

Countries citing papers authored by F. Ruiz

Since Specialization

Citations

This map shows the geographic impact of F. Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Ruiz more than expected).

Fields of papers citing papers by F. Ruiz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Ruiz. The network helps show where F. Ruiz may publish in the future.

Co-authorship network of co-authors of F. Ruiz

This figure shows the co-authorship network connecting the top 25 collaborators of F. Ruiz. A scholar is included among the top collaborators of F. Ruiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Ruiz. F. Ruiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Varghese, Nidhy P., et al.. (2023). The Role of Cascade Screening in Heritable Forms of Pulmonary Arterial Hypertension. Pulmonary Circulation. 13(3). e12259–e12259. 1 indexed citations

Varghese, Nidhy P., et al.. (2023). Prevalence of malnutrition in pediatric pulmonary hypertension cohort and role for registered dietitian involvement. Frontiers in Pediatrics. 11. 995470–995470. 3 indexed citations

Coleman, Ryan D., et al.. (2023). Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration. Frontiers in Pediatrics. 11. 1050508–1050508. 6 indexed citations

Peloquin, Charles A., et al.. (2021). Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis. Journal of Cystic Fibrosis. 21(2). 348–352. 7 indexed citations

Mallory, George B., et al.. (2021). Outcomes of COVID‐19 infection in pediatric pulmonary hypertension: A single‐center experience. Pediatric Pulmonology. 56(12). 3960–3965. 4 indexed citations

Tillman, Robert & F. Ruiz. (2020). Effect of Patent Ductus Arteriosus in Congenital Diaphragmatic Hernia Population: A Single Center Review. A4658–A4658.

Ruiz, F., et al.. (2020). Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children. Pediatric Pulmonology. 56(3). 593–613. 4 indexed citations

Pagaduan, Jayson V., et al.. (2018). Revisiting sweat chloride test results based on recent guidelines for diagnosis of cystic fibrosis. Practical Laboratory Medicine. 10. 34–37. 17 indexed citations

Dinh, Kimberly, et al.. (2016). Evaluating the safety of intermittent intravenous sildenafil in infants with pulmonary hypertension. Pediatric Pulmonology. 52(2). 232–237. 7 indexed citations

10.

Niu, Mary C., George B. Mallory, Henri Justino, F. Ruiz, & Christopher J. Petit. (2013). Treatment of Severe Pulmonary Hypertension in the Setting of the Large Patent Ductus Arteriosus. PEDIATRICS. 131(5). e1643–e1649. 17 indexed citations

11.

Cobb, Bryan, F. Ruiz, Charles M. King, et al.. (2002). A₂adenosine receptors regulate CFTR through PKA and PLA₂. American Journal of Physiology-Lung Cellular and Molecular Physiology. 282(1). L12–L25. 55 indexed citations

12.

Clancy, John P., Zsuzsa Bebők, F. Ruiz, et al.. (2001). Evidence that Systemic Gentamicin Suppresses Premature Stop Mutations in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 163(7). 1683–1692. 194 indexed citations

13.

Ruiz, F., John P. Clancy, Michael A. Perricone, et al.. (2001). A Clinical Inflammatory Syndrome Attributable to Aerosolized Lipid–DNA Administration in Cystic Fibrosis. Human Gene Therapy. 12(7). 751–761. 136 indexed citations

14.

Clancy, John P., F. Ruiz, & Eric J. Sorscher. (1999). Adenosine and its nucleotides activate wild-type and R117H CFTR through an A_2Breceptor-coupled pathway. American Journal of Physiology-Cell Physiology. 276(2). C361–C369. 69 indexed citations

15.

Venglarik, Charles J., G Aubin, Mark Weatherly, et al.. (1997). Relationship Between Airway Ion Transport and a Mild Pulmonary Disease Mutation in CFTR. American Journal of Respiratory and Critical Care Medicine. 155(5). 1684–1689. 33 indexed citations

16.

Ruiz, F., et al.. (1991). [Acipimox in primary hyperlipidemias: safety and efficacy evaluated in six months].. PubMed. 119(10). 1140–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact